Adverse effects registry considered a high priority by OAM advisory council.
This article was originally published in The Tan Sheet
ALTERNATIVE MEDICINE ADVERSE EFFECTS REGISTRY IS HIGH PRIORITY FOR OAM, members of the Office of Alternative Medicine's program advisory council agreed at a Feb. 27 meeting in Bethesda, Md. OAM Director Wayne Jonas, MD, posited the registry as one of several potential priorities for the office, asking for the council's recommendations. "I think the adverse effects registry is something that is going to be very important" in order to make decisions about "benefit-to-risk ratios" of disease treatments, he commented.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC